45 related articles for article (PubMed ID: 37470572)
1. A plan comparison study between rapid arc and conventional intensity-modulated radiation treatment plans in nasopharyngeal carcinoma patients.
Patidar Y; Kumar HS; Sharma N; Mayilvaganan A
J Cancer Res Ther; 2023; 19(3):543-547. PubMed ID: 37470572
[TBL] [Abstract][Full Text] [Related]
2. Automatic IMRT treatment planning through fluence prediction and plan fine-tuning for nasopharyngeal carcinoma.
Cai W; Ding S; Li H; Zhou X; Dou W; Zhou L; Song T; Li Y
Radiat Oncol; 2024 Mar; 19(1):39. PubMed ID: 38509540
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal Cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in total scalp irradiation: a single institutional experience.
Ostheimer C; Hübsch P; Janich M; Gerlach R; Vordermark D
Radiat Oncol J; 2016 Dec; 34(4):313-321. PubMed ID: 27951625
[TBL] [Abstract][Full Text] [Related]
5. RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.
Zhai DY; Yin Y; Gong GZ; Liu TH; Chen JH; Ma CS; Lu J
J Radiat Res; 2013 Jan; 54(1):166-73. PubMed ID: 23283869
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison between carotid-sparing IMRT and 3DCRT in early glottic cancer patients treated with definitive radiation therapy.
Kaur H; Thakur N; Sharma R; Sudan M; Jain N; Kaur S; Lehal P
J Cancer Res Ther; 2024 Jan; 20(1):327-332. PubMed ID: 38554342
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
[No Abstract] [Full Text] [Related]
8. Automatic Planning for Nasopharyngeal Carcinoma Based on Progressive Optimization in RayStation Treatment Planning System.
Yang Y; Shao K; Zhang J; Chen M; Chen Y; Shan G
Technol Cancer Res Treat; 2020; 19():1533033820915710. PubMed ID: 32552600
[TBL] [Abstract][Full Text] [Related]
9. Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.
Doornaert P; Verbakel WF; Rietveld DH; Slotman BJ; Senan S
Radiat Oncol; 2011 Jun; 6():74. PubMed ID: 21679401
[TBL] [Abstract][Full Text] [Related]
10. A quality control method for intensity-modulated radiation therapy planning based on generalized equivalent uniform dose.
Pang H; Sun X; Yang B; Wu J
J Appl Clin Med Phys; 2018 May; 19(3):276-282. PubMed ID: 29696777
[TBL] [Abstract][Full Text] [Related]
11. Comparison of simple and complex liver intensity modulated radiotherapy.
Lee MT; Purdie TG; Eccles CL; Sharpe MB; Dawson LA
Radiat Oncol; 2010 Nov; 5():115. PubMed ID: 21114865
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 3D anatomical dose verification and 2D phantom dose verification of IMRT/VMAT treatments for nasopharyngeal carcinoma.
Lin H; Huang S; Deng X; Zhu J; Chen L
Radiat Oncol; 2014 Mar; 9():71. PubMed ID: 24606879
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
Dong J; Ng WT; Wong CHL; Li JS; Bollen H; Chow JCH; Eisbruch A; Lee AWM; Lee VHF; Ng SP; Nuyts S; Smee R; Ferlito A
Radiother Oncol; 2024 Jun; 195():110258. PubMed ID: 38537680
[TBL] [Abstract][Full Text] [Related]
14. Modulated Arc Therapy for hippocampal-avoidance whole brain radiation therapy: planning comparison with intensity modulated Radiation Therapy.
Martín-Tovar EA; Badillo-Alvarado AH; Cocom-Poot LE; Gaxiola-Sosa JL
Radiat Environ Biophys; 2024 May; ():. PubMed ID: 38809486
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric influence of photon beam energy and number of arcs on volumetric modulated arc therapy in carcinoma cervix: A planning study.
Yadav G; Bhushan M; Dewan A; Saxena U; Kumar L; Chauhan D; Raman K; Mitra S; Suhail M
Rep Pract Oncol Radiother; 2017; 22(1):1-9. PubMed ID: 27790072
[TBL] [Abstract][Full Text] [Related]
16. A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma.
Gains JE; Patel A; Chang YC; Mandeville HC; Smyth G; Stacey C; Talbot J; Wheatley K; Gaze MN
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e154-e162. PubMed ID: 38553363
[TBL] [Abstract][Full Text] [Related]
17. A Neural Network-based Method for Predicting Dose to Organs at Risk in Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma.
Zhang HW; Pang HW; Wang YH; Jiang W
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):46-55. PubMed ID: 37996310
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dose distribution in IMRT and RapidArc technique in prostate radiotherapy.
Leszczyński W; Slosarek K; Szlag M
Rep Pract Oncol Radiother; 2012; 17(6):347-51. PubMed ID: 24377036
[TBL] [Abstract][Full Text] [Related]
19. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Comparison of Knowledge-Based and Manual Intensity Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma.
Hu J; Liu B; Xie W; Zhu J; Yu X; Gu H; Wang M; Wang Y; Qi Z
Front Oncol; 2020; 10():551763. PubMed ID: 33489869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
